查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092181

數位PCR與即時PCR市場－2026年至2032年全球市場預測

Digital PCR & Real-Time PCR Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，數位 PCR 和即時PCR市場將成長至 252 億美元，複合年成長率為 12.88%。

主要市場統計數據
基準年 2025 107.8億美元
預計年份：2026年 121.2億美元
預測年份 2032 252億美元
複合年成長率 (%) 12.88%

數位PCR和即時PCR執行摘要

數位PCR和即時PCR已成為分子診斷和生命科學研究的基礎技術，可在臨床、製藥、食品安全、環境和學術領域實現高靈敏度的核酸檢測、定量和監測。即時PCR（也稱為定量PCR，qPCR）因其速度快、擴充性且實驗流程成熟，在基因表現分析、病原體檢測、基因分型和病毒量監測等領域廣泛應用。數位PCR，包括液滴數位PCR和晶片式數位PCR，在絕對定量、罕見突變檢測、拷貝數變異分析、液態生物檢體研究以及低表達標靶檢測等需要更高精度和抗抑製劑性能的領域，正日益發揮其戰略重要性。精準醫療、感染疾病監測、腫瘤研究、移植監測、生殖醫學、抗生素抗藥性追蹤和分散式檢查模式等需求推動了這項發展。此外，樣品製備、多重檢測設計、自動化、試劑穩定性、數據分析軟體和符合監管標準的品管系統等方面的持續改進也促進了該領域的發展。隨著檢查室越來越重視低拷貝數結果的可重複性、週轉時間和可靠性，數位 PCR 和即時PCR擴大被用作互補平台，而不是競爭技術。

PCR技術領域的變革性變化

數位PCR和即時PCR領域正因精準診斷、自動化、小型化和資訊科學主導的檢查室操作的融合而不斷重塑。其中一個重大轉變是從單一標靶檢測向多重檢測的過渡，後者可在單一工作流程中檢測多種病原體、生物標記或基因變異，從而提高檢體處理效率並支持臨床決策。數位PCR的應用範圍正在不斷擴大，尤其是在變異性較高、需要標準化曲線和相對定量分析的應用領域，例如罕見等位基因的檢測、微量殘存疾病的調查、非侵入性產前檢測以及細胞和基因治療的載體拷貝數分析。即時PCR也在不斷發展，例如更快的熱循環、冷凍乾燥試劑、攜帶式設備以及支援疫情應對和現場檢測的整合式「樣本到結果」系統。檢查室也越來越重視污染控制、工作流程標準化以及與自動化液體處理的兼容性。監管機構對分析有效性、可追溯性和品管的要求，正迫使製造商和檢查室提高檢測方法的穩健性和完善的文件記錄。另一方面，次世代定序的興起並沒有取代 PCR；相反，在多技術分子檢測生態系統中，PCR 擴大用於正交確認、快速分類、文庫品管和標靶定量。

人工智慧對PCR工作流程的累積影響

人工智慧正透過檢測設計、訊號解讀、工作流程最佳化和檢查室決策支持，對數位PCR和即時PCR產生日益顯著的影響。人工智慧驅動的生物資訊學可以幫助識別具有更高特異性的引子和探針候選物，降低脫靶擴增的風險，評估序列變異性，並開發多重PCR檢測方案。在即時PCR中，機器學習技術被應用於擴增曲線分析、基準校正、閾值設定、質量標記以及區分真陽性、延遲擴增、引子二聚體偽影和擴增抑制反應。在數位PCR中，人工智慧可以輔助液滴或分區分類、叢集識別、罕見事件檢測和自動化品質評估，尤其是在人工審核耗時的高通量環境中。這些協同作用能夠提高結果的一致性，減少操作人員的主觀性，加快結果確認速度，並增強處理大量分子數據的檢查室的擴充性。人工智慧還支援儀器的預測性維護、試劑庫存規劃以及與實驗室資訊系統（LIS）的整合。然而，實施人工智慧需要高度透明的演算法、檢驗的資料集、網路安全措施、可審計性，以及遵守有關臨床試驗和醫療設備的法規。短期內，人工智慧的最大價值預計並非完全取代科學和臨床監管，而是增強對結果的解讀和品管。

亞太地區、北美地區、拉丁美洲地區、歐洲地區以及中東和非洲地區的關鍵區域洞察

亞太地區正崛起為數位和即時PCR活動的中心，這主要得益於中國、印度、日本、韓國、澳洲和東南亞國協分子診斷能力的不斷提升，以及感染疾病監測、癌症研究、公共衛生基因組學和生物技術基礎設施的進步。北美仍然是先進即時PCR應用的領先中心，這得益於其強大的臨床實驗室網路、活躍的學術研究、生物製藥開發、豐富的監管經驗，以及PCR技術在呼吸系統疾病監測、腫瘤學、基因檢測和治療監測中的持續應用。在拉丁美洲，公共衛生實驗室、私人診斷網路和學術機構正在加強PCR技術的應用，推動了分子檢測在感染疾病、食品安全和農業生物監測領域的應用。巴西和墨西哥尤其重要。在歐洲，成熟的診斷標準、轉化研究計畫、公共衛生合作以及對腫瘤學、罕見疾病研究、抗菌素抗藥性監測和獸醫診斷領域檢驗的分子檢測方法的強勁需求，正在推動PCR技術的進步。在中東，尤其是在對快速診斷和精準醫療能力需求旺盛的高所得海灣國家，各國正在增加對先進醫療基礎設施、基因組醫學舉措和院內分子檢查室的投資。在非洲，透過感染疾病控制計畫、參考檢查室、捐助者支持的公共衛生舉措以及區域定序和分子監測網路，PCR技術的普及程度正在不斷提高。然而，基礎設施、供應鏈可靠性、人力資源發展和成本效益仍然是更廣泛應用的關鍵決定因素。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

在東南亞國協，即時PCR和數位PCR技術的應用正透過感染疾病控制、醫院檢查室現代化、食品出口品質計畫和學術生物技術舉措不斷擴展。這種需求受到各國醫療基礎設施差異和跨境疾病監測需求的影響。在海灣合作理事會（GCC）國家，分子診斷作為醫療轉型、基因組醫學、生殖健康、腫瘤診斷和集中式檢查室。在歐盟，基於PCR的診斷技術維持著高度監管、標準主導的環境，合規性、臨床證據、互通性和統一的品質系統影響其在人類健康、獸醫學、食品安全和環境監測領域的應用。金磚國家共同構成了廣泛的PCR活動的基礎，涵蓋大規模傳染病檢查需求、國內生物技術發展、公共衛生計畫、藥物研究和精準醫療計劃，儘管各國在PCR技術的可及性和保險報銷條件方面存在顯著差異。七國集團（G7）的特點是擁有先進的臨床檢測能力、雄厚的科研經費、生物製藥創新能力，並高度重視檢驗的檢測方法、資料完整性和監管科學。北約成員國對PCR技術在生物安全、保護軍人健康、感染疾病防控和建構穩健的診斷供應鏈方面的興趣日益濃厚，這進一步加強了分子檢測在國家應急準備和衛生安全規劃中的作用。

主要國家引入數位PCR和即時PCR的趨勢

美國是數位和即時PCR在臨床診斷、腫瘤研究、感染疾病監測、藥物研發和檢查室自建檢測（LDT）領域應用的領先中心，這得益於其廣泛的分子檢測基礎設施和轉化研究活動。加拿大則強調PCR技術在公共衛生、基因組學研究、腫瘤學、器官移植和感染疾病監測中的應用，尤其注重品質保證和確保其地理分散的人口都能公平地獲得這些服務。墨西哥正透過其醫院網路、參考檢查室、學術機構和感染疾病計畫來擴展分子檢測，而巴西則透過公共衛生機構、研究型大學、農業生物技術和臨床診斷檢查室主導拉丁美洲的PCR活動。在英國，PCR技術被應用於國家健康計畫、基因組學研究舉措、腫瘤學、罕見疾病研究和感染疾病控制，而在德國，先進的檢查室自動化、分子診斷技術和藥物研發能力則被融合在一起。在法國，PCR技術廣泛應用於醫院診斷、公共研究、腫瘤學、微生物學和食品安全領域。在俄羅斯，PCR技術應用於感染疾病控制、獸醫診斷、生物技術和臨床檢查室。在義大利和西班牙，即時PCR即時PCRPCR技術繼續應用於醫院診斷、學術研究、生殖醫學、呼吸道病原體檢測和腫瘤相關分子分析。中國正透過大規模臨床實驗室網路、自主研發設備和試劑、進行感染疾病監測、癌症研究和精準醫療計畫來提升其PCR能力。印度正透過公共衛生基礎設施、私人診斷連鎖機構、傳染病檢查、生殖醫學、腫瘤學和生物技術研究來擴大PCR技術的普及範圍。日本以其高品質的檢測實踐、老齡化社會的醫療保健需求、腫瘤調查、伴隨診斷以及先進設備的應用而聞名。澳洲廣泛使用 PCR 技術進行公共衛生監測、獸醫和環境檢測、臨床診斷和調查，而韓國則以其快速採用分子診斷技術、強大的生物技術製造能力、感染疾病防範能力和以醫院為基礎的精準醫療計劃而聞名。

為行業領導者提供的實用建議

產業領導者應優先考慮檢測可靠性、工作流程簡化和基於證據的性能差異化，而非僅基於靈敏度來定位PCR平台。製造商和實驗室可以透過投資多重分析、自動化耗材、抗污染工作流程以及支援驗證結果解讀和檢驗追蹤的使用者友善軟體來增強其競爭優勢。數位PCR供應商應專注於絕對定量能夠帶來明確科學或臨床價值的應用，例如罕見突變分析、細胞和基因治療品管、液態生物檢體研究、病毒庫研究、拷貝數分析和低水平病原體檢測。即時PCR領域的相關人員應致力於持續改進處理時間、試劑穩定性、便攜性和整合式樣品製備，以支援分散式和高通量應用情境。與臨床實驗室、公共衛生組織、學術機構和生物製藥團隊建立合作關係，有助於產生特定應用的檢驗數據，同時拓展其在實際應用中的效用。此外，由於PCR工作流程仍易受試劑和耗材供應中斷的影響，各機構需要加強酵素、探針、塑膠製品和對照樣本等供應鏈的韌性。引進人工智慧軟體時應謹慎，確保透明的檢驗、網路安全措施和人工審核流程。最後，領導者需要根據當地監管要求、檢查室認證標準、保險報銷實際情況和人才發展需求來調整產品開發，以促進產品推廣和永續使用。

調查方法

本執行摘要採用結構化的二手研究途徑編寫，並輔以公開可查且檢驗的二手資訊的檢驗。該調查方法考慮了同行評審的科學文獻、臨床實驗室指南、監管出版刊物、公共衛生機構資料、標準文件、專利和技術趨勢綜述、疾病監測參考資料以及來自學術界、政府和醫療機構的資訊。分析從技術能力、應用有效性、對檢查室工作流程的影響、監管考慮、區域推廣促進因素和最終用戶需求等角度評估了即時PCR 。透過比較多個資訊來源類別來檢驗分析的有效性，從而最大限度地減少對單一資訊來源的依賴，並確保結論反映已記錄的行業和科學進展。本評估不涉及市場規模、市場佔有率和未來前景的收入預測，而是專注於定性證據、推廣模式、技術演進、營運影響和策略重點。基於醫療基礎設施、研究活動、公共衛生重點、診斷能力、生物技術發展和政策方向，整合了區域、群體和國家層面的具體見解，作為說明觀點。

結論

數位PCR和即時PCR仍然是現代分子檢測的兩大支柱。即時PCR具有速度快、擴充性和臨床效用價值高等優點，而數位PCR則能為日益複雜的調查和診斷挑戰提供高度精確的絕對定量分析。該領域正透過多重PCR、自動化、改進的試劑、整合的工作流程以及人工智慧驅動的數據解讀而不斷進步，但區域部署反映了醫療基礎設施、公共衛生重點、監管成熟度和生物技術投資方面的差異。最永續的策略是將科學性能與檢查室的實際需求相結合，例如可重複性、易用性、可驗證性、成本效益以及與更廣泛的分子檢測生態系統的整合。隨著精準醫療、感染疾病控制、生物製造品管和基因組監測的不斷發展，數位PCR和即時PCR將繼續作為互補技術，為更快、更可靠、更具實用性的分子水平洞察提供支援。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：數位PCR與即時PCR市場：依產品類型分類

  • 裝置
  • 試劑和耗材
    • 酵素
    • 母帶混音
    • 探針和引子
  • 服務
  • 軟體

第8章：數位PCR和即時PCR市場：按技術分類

  • 數位PCR
    • 晶片式數位PCR
    • 液滴式數位PCR
  • 即時PCR
    • 定量即時PCR
    • 逆轉錄即時PCR

第9章：數位PCR和即時PCR市場：按檢測方法分類

  • 螢光檢測法
  • 利用探針​​進行檢測
  • 利用染料進行檢測

第10章：數位PCR和即時PCR市場：按應用分類

  • 臨床應用
    • 傳染病檢查
    • 腫瘤科檢查
    • 移植診斷
  • 環境領域的應用
  • 食品安全
    • 過敏原檢測
    • 病原體檢測
  • 法醫學應用
  • 出於研究目的
    • 基因表現
    • 單細胞分析
    • 幹細胞研究

第11章 數位PCR和即時PCR市場：按最終用戶分類

  • 學術研究機構
  • 臨床診斷檢查室
  • 法醫學實驗室
  • 製藥和生物技術公司

第12章 數位PCR和即時PCR市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：數位PCR和即時PCR市場：按類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 數位PCR和即時PCR市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Analytik Jena GmbH+Co. KG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Bioneer Corporation
  • Danaher Corporation
  • Enzo Biochem, Inc.
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • GenScript Biotech Corporation
  • Hologic, Inc.
  • JN Medsys Pte Ltd.
  • LGC Limited
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Molbio Diagnostics Pvt. Ltd.
  • Promega Corporation
  • QIAGEN NV
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Revvity, Inc.
  • Seegene Inc.
  • Standard BioTools Inc.
  • Stilla Technologies SA
  • Sysmex Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-8760467AA4C1

The Digital PCR & Real-Time PCR Market is projected to grow by USD 25.20 billion at a CAGR of 12.88% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 10.78 billion
Estimated Year [2026] USD 12.12 billion
Forecast Year [2032] USD 25.20 billion
CAGR (%) 12.88%

Digital PCR & Real-Time PCR Executive Summary

Digital PCR and real-time PCR have become foundational molecular diagnostics and life science research technologies, enabling sensitive nucleic acid detection, quantification, and monitoring across clinical, pharmaceutical, food safety, environmental, and academic applications. Real-time PCR, also known as quantitative PCR or qPCR, remains widely used for gene expression analysis, pathogen detection, genotyping, and viral load monitoring because of its speed, scalability, and established laboratory workflows. Digital PCR, including droplet digital PCR and chip-based digital PCR, is gaining strategic relevance where absolute quantification, rare mutation detection, copy number variation analysis, liquid biopsy research, and low-abundance target measurement require higher precision and tolerance to inhibitors. Demand is being shaped by precision medicine, infectious disease surveillance, oncology research, transplant monitoring, reproductive health, antimicrobial resistance tracking, and decentralized testing models. The sector is also benefiting from continuous improvements in sample preparation, multiplex assay design, automation, reagent stability, data analysis software, and regulatory-grade quality systems. As laboratories prioritize reproducibility, turnaround time, and confidence in low-copy-number results, digital PCR and real-time PCR are increasingly used as complementary platforms rather than competing technologies.

Transformative Shifts in the PCR Technology Landscape

The digital PCR and real-time PCR landscape is being reshaped by the convergence of precision diagnostics, automation, miniaturization, and informatics-driven laboratory operations. A major shift is the movement from single-target assays toward multiplex panels capable of detecting multiple pathogens, biomarkers, or genetic variants in one workflow, improving sample efficiency and clinical decision support. Digital PCR adoption is strengthening in applications where standard curves and relative quantification can introduce variability, particularly in rare allele detection, minimal residual disease research, noninvasive prenatal testing research, and vector copy number analysis for cell and gene therapy. Real-time PCR continues to advance through faster thermal cycling, lyophilized reagents, portable instruments, and integrated sample-to-answer systems that support outbreak response and point-of-need testing. Laboratories are also placing greater emphasis on contamination control, workflow standardization, and compatibility with liquid handling automation. Regulatory expectations around analytical validation, traceability, and quality control are encouraging manufacturers and laboratories to improve assay robustness and documentation. At the same time, the rise of next-generation sequencing is not displacing PCR; instead, PCR is increasingly used for orthogonal confirmation, rapid triage, library quality control, and targeted quantification in multi-technology molecular testing ecosystems.

Cumulative Impact of Artificial Intelligence on PCR Workflows

Artificial intelligence is increasingly influencing digital PCR and real-time PCR through assay design, signal interpretation, workflow optimization, and laboratory decision support. AI-enabled bioinformatics can help identify primer and probe candidates with improved specificity, reduce the risk of off-target amplification, evaluate sequence variability, and support multiplex panel development. In real-time PCR, machine learning approaches are being applied to amplification curve analysis, baseline correction, threshold setting, quality flagging, and differentiation between true positives, late amplification, primer-dimer artifacts, and inhibited reactions. In digital PCR, AI can support droplet or partition classification, cluster calling, rare-event detection, and automated quality assessment, particularly in high-throughput environments where manual review is time-intensive. The cumulative impact is greater consistency, reduced operator subjectivity, faster result review, and improved scalability for laboratories managing large volumes of molecular data. AI also supports predictive maintenance for instruments, reagent inventory planning, and laboratory information system integration. However, adoption requires transparent algorithms, validated datasets, cybersecurity controls, auditability, and compliance with clinical laboratory and medical device regulations. The strongest near-term value lies in AI-assisted interpretation and quality control rather than full replacement of scientific and clinical oversight.

Key Regional Insights Across Asia-Pacific, North America, Latin America, Europe, the Middle East, and Africa

Asia-Pacific is emerging as a high-activity region for digital PCR and real-time PCR due to expanding molecular diagnostics capacity, infectious disease monitoring, oncology research, public health genomics, and growing biotechnology infrastructure across China, India, Japan, South Korea, Australia, and ASEAN economies. North America remains a leading hub for advanced PCR adoption, supported by strong clinical laboratory networks, academic research intensity, biopharmaceutical development, regulatory experience, and continued use of PCR in respiratory disease surveillance, oncology, genetic testing, and therapeutic monitoring. Latin America is strengthening PCR deployment through public health laboratories, private diagnostic networks, academic institutions, and increased use of molecular testing for infectious diseases, food safety, and agricultural biosurveillance, with Brazil and Mexico serving as important centers of activity. Europe benefits from mature diagnostic standards, translational research programs, public health coordination, and strong demand for validated molecular assays in oncology, rare disease research, antimicrobial resistance monitoring, and veterinary diagnostics. The Middle East is investing in advanced healthcare infrastructure, genomic medicine initiatives, and hospital-based molecular laboratories, particularly in high-income Gulf economies seeking rapid diagnostics and precision medicine capabilities. Africa is expanding PCR access through infectious disease programs, reference laboratories, donor-supported public health initiatives, and regional sequencing and molecular surveillance networks, although infrastructure, supply chain reliability, workforce training, and affordability remain critical determinants of broader adoption.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN countries are increasing the use of real-time PCR and digital PCR through infectious disease preparedness, hospital laboratory modernization, food export quality programs, and academic biotechnology initiatives, with demand shaped by diverse healthcare infrastructure and cross-border disease surveillance needs. GCC countries are prioritizing molecular diagnostics as part of healthcare transformation, genomic medicine, reproductive health, oncology diagnostics, and centralized laboratory automation, supported by investments in tertiary care and national health strategies. The European Union maintains a highly regulated and standards-driven environment for PCR-based diagnostics, where compliance, clinical evidence, interoperability, and harmonized quality systems influence adoption across human health, veterinary health, food safety, and environmental monitoring. BRICS countries collectively represent a broad base of PCR activity, spanning large infectious disease testing needs, domestic biotechnology development, public health programs, pharmaceutical research, and precision medicine initiatives, while access and reimbursement conditions vary substantially by country. G7 economies are characterized by advanced clinical laboratory capabilities, strong research funding, biopharmaceutical innovation, and high emphasis on validated assays, data integrity, and regulatory science. NATO member countries show rising interest in PCR technologies for biosecurity, force health protection, outbreak readiness, and resilient diagnostic supply chains, reinforcing the role of molecular testing in national preparedness and health security planning.

Key Country Insights for Digital PCR and Real-Time PCR Adoption

The United States is a major center for digital PCR and real-time PCR use across clinical diagnostics, oncology research, infectious disease surveillance, pharmaceutical development, and laboratory-developed testing, supported by extensive molecular laboratory infrastructure and translational research activity. Canada emphasizes PCR applications in public health, genomic research, oncology, transplantation, and infectious disease monitoring, with strong attention to quality assurance and equitable access across geographically dispersed populations. Mexico is expanding molecular testing through hospital networks, reference laboratories, academic centers, and infectious disease programs, while Brazil leads PCR activity in Latin America through public health institutions, research universities, agricultural biotechnology, and clinical diagnostic laboratories. The United Kingdom applies PCR technologies across national health programs, genomics initiatives, oncology, rare disease research, and infectious disease preparedness, while Germany combines strong laboratory automation, molecular diagnostics expertise, and pharmaceutical research capacity. France maintains broad PCR adoption in hospital diagnostics, public research, oncology, microbiology, and food safety, while Russia applies PCR across infectious disease control, veterinary diagnostics, biotechnology, and clinical laboratory settings. Italy and Spain continue to use real-time PCR and digital PCR in hospital diagnostics, academic research, reproductive health, respiratory pathogen testing, and oncology-related molecular analysis. China is advancing PCR capabilities through large-scale clinical testing networks, domestic instrument and reagent development, infectious disease surveillance, cancer research, and precision medicine programs. India is expanding PCR access through public health infrastructure, private diagnostic chains, infectious disease testing, reproductive health, oncology, and biotechnology research. Japan is distinguished by high-quality laboratory practices, aging-population healthcare needs, oncology research, companion diagnostics, and advanced instrumentation adoption. Australia uses PCR extensively in public health surveillance, veterinary and environmental testing, clinical diagnostics, and research, while South Korea is recognized for rapid molecular diagnostics deployment, strong biotechnology manufacturing, infectious disease readiness, and hospital-based precision medicine programs.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize assay reliability, workflow simplicity, and evidence-based performance differentiation rather than positioning PCR platforms only around sensitivity claims. Manufacturers and laboratories can strengthen competitiveness by investing in multiplexing, automation-ready consumables, contamination-resistant workflows, and user-friendly software that supports validated interpretation and audit trails. Digital PCR providers should focus on applications where absolute quantification creates clear scientific or clinical value, including rare variant analysis, cell and gene therapy quality control, liquid biopsy research, viral reservoir studies, copy number analysis, and low-level pathogen detection. Real-time PCR stakeholders should continue improving turnaround time, reagent stability, portability, and integrated sample preparation to support decentralized and high-throughput use cases. Partnerships with clinical laboratories, public health agencies, academic centers, and biopharmaceutical teams can help generate application-specific validation data while expanding real-world utility. Organizations should also strengthen supply chain resilience for enzymes, probes, plastics, and controls, as PCR workflows remain vulnerable to reagent and consumable disruptions. AI-enabled software should be deployed cautiously with transparent validation, cybersecurity safeguards, and human-review pathways. Finally, leaders should align product development with regional regulatory requirements, laboratory accreditation standards, reimbursement realities, and workforce training needs to improve adoption and sustained use.

Research Methodology

This executive summary is developed using a structured secondary research approach supported by triangulation of publicly available, verifiable sources. The methodology considers peer-reviewed scientific literature, clinical laboratory guidelines, regulatory publications, public health agency materials, standards documents, patent and technology trend reviews, disease surveillance references, and information from academic, government, and healthcare institutions. The analysis evaluates digital PCR and real-time PCR across technology functionality, application relevance, laboratory workflow impact, regulatory considerations, regional adoption drivers, and end-user requirements. Insights are validated through cross-comparison of multiple source categories to minimize reliance on single-point claims and to ensure that conclusions reflect documented industry and scientific developments. The assessment excludes market sizing, market share, and forward-looking revenue forecasts, focusing instead on qualitative evidence, adoption patterns, technology shifts, operational implications, and strategic priorities. Regional, group, and country insights are synthesized into narrative perspectives based on healthcare infrastructure, research intensity, public health priorities, diagnostic capacity, biotechnology development, and policy direction.

Conclusion

Digital PCR and real-time PCR remain essential pillars of modern molecular testing, with real-time PCR delivering speed, scalability, and established clinical utility, and digital PCR providing high-precision absolute quantification for increasingly complex research and diagnostic challenges. The sector is advancing through multiplexing, automation, improved reagents, integrated workflows, and AI-assisted data interpretation, while regional adoption reflects differences in healthcare infrastructure, public health priorities, regulatory maturity, and biotechnology investment. The most resilient strategies will be those that connect scientific performance with practical laboratory needs, including reproducibility, usability, validation, cost efficiency, and integration with broader molecular testing ecosystems. As precision medicine, infectious disease preparedness, biomanufacturing quality control, and genomic surveillance continue to evolve, digital PCR and real-time PCR will remain complementary technologies supporting faster, more reliable, and more actionable molecular insights.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Digital PCR & Real-Time PCR Market, by Product Type

  • 7.1. Introduction
  • 7.2. Instruments
  • 7.3. Reagents & Consumables
    • 7.3.1. Enzymes
    • 7.3.2. Master Mixes
    • 7.3.3. Probes & Primers
  • 7.4. Services
  • 7.5. Software

8. Digital PCR & Real-Time PCR Market, by Technology

  • 8.1. Introduction
  • 8.2. Digital PCR
    • 8.2.1. Chip-Based Digital PCR
    • 8.2.2. Droplet Digital PCR
  • 8.3. Real-Time PCR
    • 8.3.1. Quantitative Real-Time PCR
    • 8.3.2. Reverse Transcription Real-Time PCR

9. Digital PCR & Real-Time PCR Market, by Detection Method

  • 9.1. Introduction
  • 9.2. Fluorescent Detection
  • 9.3. Probe Based Detection
  • 9.4. Dye Based Detection

10. Digital PCR & Real-Time PCR Market, by Application

  • 10.1. Introduction
  • 10.2. Clinical Applications
    • 10.2.1. Infectious Disease Testing
    • 10.2.2. Oncology Testing
    • 10.2.3. Transplant Diagnostics
  • 10.3. Environmental Applications
  • 10.4. Food Safety
    • 10.4.1. Allergen Testing
    • 10.4.2. Pathogen Testing
  • 10.5. Forensic Application
  • 10.6. Research Applications
    • 10.6.1. Gene Expression
    • 10.6.2. Single Cell Analysis
    • 10.6.3. Stem Cell Research

11. Digital PCR & Real-Time PCR Market, by End-User

  • 11.1. Introduction
  • 11.2. Academic & Research Institutes
  • 11.3. Clinical Diagnostics Laboratories
  • 11.4. Forensic Labs
  • 11.5. Pharmaceutical & Biotechnology Companies

12. Digital PCR & Real-Time PCR Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Digital PCR & Real-Time PCR Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Digital PCR & Real-Time PCR Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Agilent Technologies, Inc.
  • 16.3. Analytik Jena GmbH+Co. KG
  • 16.4. Becton, Dickinson and Company
  • 16.5. Bio-Rad Laboratories, Inc.
  • 16.6. bioMerieux S.A.
  • 16.7. Bioneer Corporation
  • 16.8. Danaher Corporation
  • 16.9. Enzo Biochem, Inc.
  • 16.10. Eppendorf SE
  • 16.11. F. Hoffmann-La Roche Ltd.
  • 16.12. GenScript Biotech Corporation
  • 16.13. Hologic, Inc.
  • 16.14. JN Medsys Pte Ltd.
  • 16.15. LGC Limited
  • 16.16. Merck KGaA
  • 16.17. Meridian Bioscience, Inc.
  • 16.18. Molbio Diagnostics Pvt. Ltd.
  • 16.19. Promega Corporation
  • 16.20. QIAGEN N.V.
  • 16.21. QuidelOrtho Corporation
  • 16.22. Randox Laboratories Ltd.
  • 16.23. Revvity, Inc.
  • 16.24. Seegene Inc.
  • 16.25. Standard BioTools Inc.
  • 16.26. Stilla Technologies SA
  • 16.27. Sysmex Corporation
  • 16.28. Takara Bio Inc.
  • 16.29. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MASTER MIXES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MASTER MIXES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MASTER MIXES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PROBES & PRIMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PROBES & PRIMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PROBES & PRIMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DIGITAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIGITAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIGITAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CHIP-BASED DIGITAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CHIP-BASED DIGITAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CHIP-BASED DIGITAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DROPLET DIGITAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DROPLET DIGITAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DROPLET DIGITAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL QUANTITATIVE REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL QUANTITATIVE REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL QUANTITATIVE REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL REVERSE TRANSCRIPTION REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL REVERSE TRANSCRIPTION REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL REVERSE TRANSCRIPTION REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FLUORESCENT DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FLUORESCENT DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FLUORESCENT DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PROBE BASED DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PROBE BASED DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PROBE BASED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DYE BASED DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DYE BASED DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DYE BASED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CLINICAL APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CLINICAL APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CLINICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ONCOLOGY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ONCOLOGY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENVIRONMENTAL APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENVIRONMENTAL APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENVIRONMENTAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FOOD SAFETY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FOOD SAFETY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FOOD SAFETY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ALLERGEN TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ALLERGEN TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ALLERGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PATHOGEN TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PATHOGEN TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PATHOGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FORENSIC APPLICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FORENSIC APPLICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FORENSIC APPLICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RESEARCH APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RESEARCH APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RESEARCH APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GENE EXPRESSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GENE EXPRESSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GENE EXPRESSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL STEM CELL RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL STEM CELL RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL STEM CELL RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CLINICAL DIAGNOSTICS LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CLINICAL DIAGNOSTICS LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CLINICAL DIAGNOSTICS LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL FORENSIC LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL FORENSIC LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL FORENSIC LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 193. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 196. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 198. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 199. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 200. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 202. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 203. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 204. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 229. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 230. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 232. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 234. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 235. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 236. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 238. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 239. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 240. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 241. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 242. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 244. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 246. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 247. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 248. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 250. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 251. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 252. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 253. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 266. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 269. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 271. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 272. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 273. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 275. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 276. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 277. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 278. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 279. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 281. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 282. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 283. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 284. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 285. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 287. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 288. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 289. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 290. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 293. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 295. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 296. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 297. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 298. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 299. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 300. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 301. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 314. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 315. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 317. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 318. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 319. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 320. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 321. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 322. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 323. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 324. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 325. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 326. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 327. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 329. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 330. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 331. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 332. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 333. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 334. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 335. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 336. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2